HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

John Choi Selected Research

Phosphotransferases (Kinase)

2/2016Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


John Choi Research Topics

Disease

17Neoplasms (Cancer)
02/2022 - 02/2016
9Glioblastoma (Glioblastoma Multiforme)
02/2022 - 01/2019
9Glioma (Gliomas)
02/2022 - 01/2018
5Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022 - 01/2019
3Residual Neoplasm
01/2022 - 10/2019
3Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2021 - 12/2019
2Brain Neoplasms (Brain Tumor)
01/2020 - 01/2019
2Leukemia
10/2019 - 08/2014
2Hepatitis C
01/2019 - 01/2018
2Glaucoma
04/2007 - 01/2005
2Open-Angle Glaucoma (Glaucoma, Open Angle)
06/2005 - 01/2005
1Pain (Aches)
02/2022
1Melanoma (Melanoma, Malignant)
02/2022
1Fever (Fevers)
01/2022
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022
1Hand-Foot Syndrome
01/2022
1Exanthema (Rash)
01/2022
1Neoplasm Metastasis (Metastasis)
01/2022
1Intracranial Aneurysm (Cerebral Aneurysm)
01/2021
1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
01/2021
1Sepsis (Septicemia)
01/2020
1Peripheral Nervous System Diseases (PNS Diseases)
01/2020
1Infections
01/2020
1Cardiomyopathies (Cardiomyopathy)
10/2019
1Second Primary Neoplasms (Neoplasms, Second)
10/2019
1Atlanto-Axial Fusion
03/2019
1Gliosarcoma
01/2019
1Breast Neoplasms (Breast Cancer)
01/2019
1Squamous Cell Carcinoma of Head and Neck
01/2019
1Hematologic Neoplasms (Hematological Malignancy)
02/2018
1Rhabdoid Tumor (Rhabdoid Tumors)
01/2018
1Wounds and Injuries (Trauma)
01/2018
1Diabetes Mellitus
01/2017
1Histiocytosis
02/2016
1Type 2 Diabetes Mellitus (MODY)
01/2016
1Body Weight (Weight, Body)
08/2014
1Myeloid Sarcoma (Chloroma)
02/2014
1Hodgkin Disease (Hodgkin's Disease)
02/2014
1Sclerosis
02/2014
1Fistula
10/2010
1Anemia
08/2010
1Diverticular Diseases
01/2010

Drug/Important Bio-Agent (IBA)

3Immune Checkpoint InhibitorsIBA
02/2022 - 01/2018
3Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2020
2Programmed Cell Death 1 ReceptorIBA
02/2022 - 01/2018
2Cytarabine (Cytosar-U)FDA LinkGeneric
01/2022 - 10/2019
2Sorafenib (BAY 43-9006)FDA Link
01/2022 - 02/2016
2Pharmaceutical PreparationsIBA
01/2020 - 01/2019
2Etoposide (VP 16)FDA LinkGeneric
10/2019 - 01/2019
2GuanosineIBA
01/2019 - 01/2018
2Ribavirin (Virazole)FDA LinkGeneric
01/2019 - 01/2018
2GlucokinaseIBA
01/2017 - 01/2016
2DorzagliatinIBA
01/2017 - 01/2016
1Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA
02/2022
1LuciferasesIBA
02/2022
1Glutamic Acid (Glutamate)FDA Link
02/2022
1CalciumIBA
01/2022
1EnzymesIBA
01/2021
1HydrogelsIBA
01/2021
1Proteins (Proteins, Gene)FDA Link
01/2021
1Therapeutic UsesIBA
01/2021
1B7-H1 AntigenIBA
01/2020
1Cell-Free Nucleic AcidsIBA
01/2020
1ACT001IBA
01/2020
1poly(beta-amino ester)IBA
01/2020
1AntibodiesIBA
01/2020
1Thymidine KinaseIBA
01/2020
1Messenger RNA (mRNA)IBA
01/2020
1Bortezomib (Velcade)FDA Link
01/2020
1Clofarabine (Clolar)FDA Link
10/2019
1Daunorubicin (Cerubidine)FDA LinkGeneric
10/2019
1AnthracyclinesIBA
10/2019
1AntigensIBA
04/2019
1recombinant human bone morphogenetic protein-2IBA
03/2019
1Ointments (Pastes)IBA
01/2019
1Temozolomide (Temodar)FDA LinkGeneric
01/2019
1Antiviral Agents (Antivirals)IBA
01/2019
1poliferprosan 20 drug combination carmustine (Gliadel)FDA Link
01/2019
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2018
1Phosphotransferases (Kinase)IBA
02/2016
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
02/2016
1plerixaforFDA Link
08/2014
1GlobulinsIBA
08/2014
1Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric
08/2014
1fludarabineIBA
08/2014
1Melphalan (Alkeran)FDA LinkGeneric
08/2014
1surgisisIBA
10/2010
1Oxidants (Oxidizing Agents)IBA
08/2010

Therapy/Procedure

15Therapeutics
01/2022 - 01/2005
7Immunotherapy
02/2022 - 01/2018
6Drug Therapy (Chemotherapy)
01/2022 - 01/2019
1Drug Tapering
01/2022
1Neoadjuvant Therapy
02/2021
1Radiotherapy
01/2020
1Cranial Irradiation
12/2019
1Remission Induction
10/2019
1Adjuvant Radiotherapy
01/2019
1Transplantation
02/2018
1Glycemic Control
01/2016
1Hematopoietic Stem Cell Transplantation
08/2014